Urine Polymerase Chain Reaction Tests
Customize your policy alerts
Sign up for longevityhealthplanofcolorado Policy UM.049 alerts
Get alerted when Policy UM.049 changes without checking for updates manually.
Monitor payer policy activity
Defines Longevity Health Plan of Colorado's coverage stance and clinical rationale for urine PCR testing for suspected urinary tract infections, primarily in long-term care populations and providers who order these tests.
Coverage Determination and Rationale
Not Medically Necessary / Not Covered
Covered when ALL of the following are met:
Use of urine PCR may produce misleading results and contribute to inappropriate antibiotic use; see literature review.
Based on the available literature, urine PCR testing for diagnosis of urinary tract infections in the long-term care population is excluded from coverage by Longevity Health Plan of Colorado.
Urine PCR is considered not medically necessary for diagnosing urinary tract infections in the long-term care population because evidence does not demonstrate it is more effective than current testing strategies. Additionally, urine PCR results can be misleading and may lead to overtreatment, which undermines antibiotic stewardship. There is no evidence that use of this test improves patient outcomes.
Provider Requirements and Billing Impact
Prior authorization will not make urine PCR payable
Urine PCR testing is not a covered service; prior authorization cannot make an otherwise non-covered urine PCR test payable.
Preferred testing pathway: urinalysis and urine culture first
Continue to use standard diagnostic testing for suspected UTI—specifically urinalysis and urine culture—before considering alternative diagnostics such as urine PCR.
- Historically, diagnosis of UTIs has been informed by urinalysis or urine culture [[source]].
Documentation expectations for suspected UTI and testing rationale
Document clinical assessment for suspected urinary tract infection and the rationale for any testing ordered; do not substitute urine PCR for urinalysis or urine culture without explicit, documented justification.
- Record signs/symptoms prompting evaluation for UTI and why standard tests were insufficient if PCR is considered.
- Note that urine PCR is a molecular test detecting bacterial DNA and is not supported as a routine alternative to urinalysis or urine culture.
Denial trigger: noncovered urine PCR claims
Claims for urine PCR testing will be denied because urine PCR is not covered for the long-term care population based on available literature.
- Coverage position: urine PCR testing will not be covered as there is no evidence to support its use in the long-term care population.
Key Definitions
Test Ordering Guidance
Ordering should rely on urinalysis and culture
Order urinalysis and urine culture as the initial diagnostic tests for suspected UTI; urine PCR is not recommended as an alternative diagnostic test in this setting.
- Do not substitute urine PCR for urinalysis or urine culture when evaluating suspected UTI in long‑term care
Background and Context
Urine PCR is a molecular diagnostic that detects bacterial DNA in urine and has been promoted as a rapid diagnostic option in long-term care settings. Historically, UTI diagnosis has relied on urinalysis and urine culture; available literature does not show urine PCR improves identification or outcomes and raises concerns about leading to inappropriate antibiotic use.
Explicit Non-Covered Services
Urine PCR testing to diagnose urinary tract infections in the long-term care population is not covered.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.